Acts, filings and financial milestones
Deadline for the 2026 accounts:
2026
31-08
micro format · 31 days late
2025
31-12
Financial
Weakest financial yearnet -€513,266
The net result drops to -€513,266, the lowest from 2022 to 2025.
31-12
Financial
Equity above €2mequity €2.3m ▲554%
Equity rises from €358,824 to €2.3m.
23-12
Gazette deed
Permanent representative: TASSENOY HenriShareholding · Capital contribution9 points ▸
Gazette deed
Permanent representative: TASSENOY Henri
Shareholding · Capital contribution9 points ▸
- General meeting, 18-12-2025
- NITYA holds all the shares
- Other provision, “administrateur, représentation de l’actionnaire unique” (deed in French), mentioned 2 times in the deed
- Permanent representative, TASSENOY Henri (représentant permanant)
- Other provision, “statuts non modifiés” (deed in French)
- Capital contribution, €2,500,000, mentioned 3 times in the deed
- Other provision, “prix d’émission et conséquences sur droits patrimoniaux et sociaux, renonciation aux rapports de l’organe d’administration” (deed in French)
- Other provision, 15-12-2025, mentioned 2 times in the deed
- Other provision, “droit d'écriture”, 100 (deed in French)
05-08
micro format · 5 days late
23-07
Gazette deed
Registered office moved from Genval to UccleNew seat: chaussée de Waterloo 1139 à 1180 Uccle · Previous seat: Centenaire cinquième avenue 5, 1332 Genval · Resignations: Céline BUYSE (director) and Marc BUYSE (director)10 points ▸
Gazette deed
Registered office moved from Genval to Uccle
New seat: chaussée de Waterloo 1139 à 1180 Uccle · Previous seat: Centenaire cinquième avenue 5, 1332 Genval · Resignations: Céline BUYSE (director) and Marc BUYSE (director)10 points ▸
- General meeting, 01-05-2025
- Registered-office move, chaussée de Waterloo 1139 à 1180 Uccle
- Director resignation, Céline BUYSE (director)
- Director discharge, Céline BUYSE
- Director appointment, NITYA (director and day-to-day manager)
- Permanent representative, Céline BUYSE (administratrice déléguée)
- Director resignation, Marc BUYSE (director)
- Director discharge, Marc BUYSE
- Director appointment, CLINIMETRICS (director)
- Permanent representative, Marc BUYSE (managing director)
2024
26-05
micro format · 66 days before the deadline
2023
06-08
micro format · 6 days late
2022
31-01
Gazette deed
IncorporationStarting capital €1,000,000 · Appointments: BUYSE Marc (director) and BUYSE Céline (director) · Founder11 points ▸
Gazette deed
Incorporation
Starting capital €1,000,000 · Appointments: BUYSE Marc (director) and BUYSE Céline (director) · Founder11 points ▸
- Founder, CLINIMETRICS
- Incorporation, 27-01-2022
- Founding capital, €1,000,000
- CLINIMETRICS holds all the shares
- Other provision, “arrêt des statuts, arrêter les statuts de la société” (deed in French)
- Capital
- Registered office clause, “1332 Rixensart (Genval), Centenaire 5e avenue 5, dépôt greffe expédition acte constitutif” (deed in French)
- Board rule, 2
- Director appointment, BUYSE Marc (director (not named in the articles))
- Director appointment, BUYSE Céline (director (not named in the articles))
- Pre-incorporation commitments, “takeover”, 23-11-2021 (deed in French)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank